Hashad Mohamed Wa'el Ahmed
- SEC CIK
- 0001966752
No open-market purchases or sales filed in the past year.
Current role at each company
- LGVN Longeveron Inc.Chief Executive Officeras of Jul 17, 2025
- AKTX Akari Therapeutics PlcDirectoras of Jul 2, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hashad Mohamed Wa'el Ahmed as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LGVN Longeveron Inc.
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 11 | 1 day | Hashad Mohamed Wa'el AhmedChief Executive Officer | PPurchaseClass A Common Stock | +10.6K | $2.35 | +$25.0K | +118.5%19.6K after | |
| Apr 12, 2024 (view filing)7:00 PM ET | Apr 11 | 1 day | Hashad Mohamed Wa'el AhmedChief Executive Officer | PPurchaseClass A Common Stock | +10.6K | $0.125 | +$1.33K | –10.6K after | Derivative |
| Sep 13, 2023 (view filing)5:00 PM ET | Sep 12 | 1 day | Hashad Mohamed Wa'el AhmedChief Executive Officer | SSale | −13.4K | $0.0164 | −$219.98 | –82.5K after | Derivative7 lots |